|
SCFD2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.05109995444053E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.35160043952021E-10 |
| Normal-vs-Stage2 |
2.547700E-02 |
| Normal-vs-Stage3 |
1.354060E-02 |
| Normal-vs-Stage4 |
7.78290000000847E-05 |
| Stage1-vs-Stage2 |
1.762430E-01 |
| Stage1-vs-Stage3 |
1.470590E-01 |
| Stage1-vs-Stage4 |
8.346200E-01 |
| Stage2-vs-Stage3 |
9.662600E-01 |
| Stage2-vs-Stage4 |
3.431800E-01 |
| Stage3-vs-Stage4 |
3.408200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.91500000301659E-08 |
| Normal-vs-AfricanAmerican |
2.127900000648E-08 |
| Normal-vs-Asian |
8.434000E-02 |
| Caucasian-vs-AfricanAmerican |
3.094800E-01 |
| Caucasian-vs-Asian |
5.285600E-01 |
| AfricanAmerican-vs-Asian |
7.691600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.12400011309921E-10 |
| Normal-vs-Female |
1.235510E-03 |
| Male-vs-Female |
3.277600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.566030E-04 |
| Normal-vs-Extreme_Weight |
8.93970009130385E-10 |
| Normal-vs-Obese |
2.20029999999927E-05 |
| Normal-vs-Extreme_Obese |
6.1325000000001E-05 |
| Normal_Weight-vs-Extreme_Weight |
2.814600E-01 |
| Normal_Weight-vs-Obese |
7.441800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.863400E-01 |
| Extreme_Weight-vs-Obese |
9.256500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.326000E-01 |
| Obese-vs-Extreme_Obese |
3.123600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.460170E-02 |
| Normal-vs-Age(41-60Yrs) |
8.26070001291868E-09 |
| Normal-vs-Age(61-80Yrs) |
4.02719999570422E-08 |
| Normal-vs-Age(81-100Yrs) |
9.74249999999843E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.258200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.947600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.716800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.405600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.809800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.396800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.13530312823218E-11 |
| Normal-VS-Type2 PRCC |
1.964830E-03 |
| Normal-VS-KIRP CIMP |
2.253700E-02 |
| Normal-VS-Unclassified PRCC |
1.029620E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.822920E-03 |
| Type1 PRCC-VS-KIRP CIMP |
8.171800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.559400E-03 |
| Type2 PRCC-VS-KIRP CIMP |
1.358620E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.587200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.299790E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.71206999999285E-05 |
| Normal-vs-N1 |
1.819320E-03 |
| Normal-vs-N2 |
5.627800E-01 |
| N0-vs-N1 |
8.095400E-01 |
| N0-vs-N2 |
4.007000E-01 |
| N1-vs-N2 |
4.181400E-01 |
|
|
